458 related articles for article (PubMed ID: 29986386)
21. Full-Length Isoforms of Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Accumulate in the Cytoplasm of Cells Undergoing the Lytic Cycle of Replication.
Garrigues HJ; Howard K; Barcy S; Ikoma M; Moses AV; Deutsch GH; Wu D; Ueda K; Rose TM
J Virol; 2017 Dec; 91(24):. PubMed ID: 28978712
[TBL] [Abstract][Full Text] [Related]
22. Suppression of Kaposi's Sarcoma-Associated Herpesvirus Infection and Replication by 5'-AMP-Activated Protein Kinase.
Cheng F; He M; Jung JU; Lu C; Gao SJ
J Virol; 2016 Jul; 90(14):6515-6525. PubMed ID: 27147746
[TBL] [Abstract][Full Text] [Related]
23. Global epigenomic analysis of KSHV-infected primary effusion lymphoma identifies functional
Park A; Oh S; Jung KL; Choi UY; Lee HR; Rosenfeld MG; Jung JU
Proc Natl Acad Sci U S A; 2020 Sep; 117(35):21618-21627. PubMed ID: 32817485
[TBL] [Abstract][Full Text] [Related]
24. KSHV RTA Induces Degradation of the Host Transcription Repressor ID2 To Promote the Viral Lytic Cycle.
Combs LR; Spires LM; Alonso JD; Papp B; Toth Z
J Virol; 2022 Jun; 96(12):e0010122. PubMed ID: 35604218
[TBL] [Abstract][Full Text] [Related]
25. The KSHV ORF20 Protein Interacts with the Viral Processivity Factor ORF59 and Promotes Viral Reactivation.
Hoffman D; Rodriguez W; Macveigh-Fierro D; Miles J; Muller M
Microbiol Spectr; 2021 Sep; 9(1):e0014521. PubMed ID: 34106579
[TBL] [Abstract][Full Text] [Related]
26. The gammaherpesviruses Kaposi's sarcoma-associated herpesvirus and murine gammaherpesvirus 68 modulate the Toll-like receptor-induced proinflammatory cytokine response.
Bussey KA; Reimer E; Todt H; Denker B; Gallo A; Konrad A; Ottinger M; Adler H; Stürzl M; Brune W; Brinkmann MM
J Virol; 2014 Aug; 88(16):9245-59. PubMed ID: 24899179
[TBL] [Abstract][Full Text] [Related]
27. STAT3 Regulates Lytic Activation of Kaposi's Sarcoma-Associated Herpesvirus.
King CA; Li X; Barbachano-Guerrero A; Bhaduri-McIntosh S
J Virol; 2015 Nov; 89(22):11347-55. PubMed ID: 26339061
[TBL] [Abstract][Full Text] [Related]
28. Targeting Kaposi's Sarcoma-Associated Herpesvirus ORF21 Tyrosine Kinase and Viral Lytic Reactivation by Tyrosine Kinase Inhibitors Approved for Clinical Use.
Beauclair G; Naimo E; Dubich T; Rückert J; Koch S; Dhingra A; Wirth D; Schulz TF
J Virol; 2020 Feb; 94(5):. PubMed ID: 31826996
[TBL] [Abstract][Full Text] [Related]
29. Kaposi's Sarcoma-Associated Herpesvirus Nonstructural Membrane Protein pK15 Recruits the Class II Phosphatidylinositol 3-Kinase PI3K-C2α To Activate Productive Viral Replication.
Abere B; Samarina N; Gramolelli S; Rückert J; Gerold G; Pich A; Schulz TF
J Virol; 2018 Sep; 92(17):. PubMed ID: 29950425
[TBL] [Abstract][Full Text] [Related]
30. HIV-1 Vpr Inhibits Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication by Inducing MicroRNA miR-942-5p and Activating NF-κB Signaling.
Yan Q; Shen C; Qin J; Li W; Hu M; Lu H; Qin D; Zhu J; Gao SJ; Lu C
J Virol; 2016 Oct; 90(19):8739-53. PubMed ID: 27440900
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of Kaposi's sarcoma-associated herpesvirus lytic replication by HIV-1 Nef and cellular microRNA hsa-miR-1258.
Yan Q; Ma X; Shen C; Cao X; Feng N; Qin D; Zeng Y; Zhu J; Gao SJ; Lu C
J Virol; 2014 May; 88(9):4987-5000. PubMed ID: 24554664
[TBL] [Abstract][Full Text] [Related]
32. Chromatin remodeling controls Kaposi's sarcoma-associated herpesvirus reactivation from latency.
Hopcraft SE; Pattenden SG; James LI; Frye S; Dittmer DP; Damania B
PLoS Pathog; 2018 Sep; 14(9):e1007267. PubMed ID: 30212584
[TBL] [Abstract][Full Text] [Related]
33. Upregulation of MicroRNA 711 Mediates HIV-1 Vpr Promotion of Kaposi's Sarcoma-Associated Herpesvirus Latency and Induction of Pro-proliferation and Pro-survival Cytokines by Targeting the Notch/NF-κB-Signaling Axis.
Yan Q; Zhao R; Shen C; Wang F; Li W; Gao SJ; Lu C
J Virol; 2018 Sep; 92(18):. PubMed ID: 29976660
[TBL] [Abstract][Full Text] [Related]
34. Negative elongation factor-mediated suppression of RNA polymerase II elongation of Kaposi's sarcoma-associated herpesvirus lytic gene expression.
Toth Z; Brulois KF; Wong LY; Lee HR; Chung B; Jung JU
J Virol; 2012 Sep; 86(18):9696-707. PubMed ID: 22740393
[TBL] [Abstract][Full Text] [Related]
35. Kaposi's Sarcoma-Associated Herpesvirus Fine-Tunes the Temporal Expression of Late Genes by Manipulating a Host RNA Quality Control Pathway.
Ruiz JC; Devlin AM; Kim J; Conrad NK
J Virol; 2020 Jul; 94(14):. PubMed ID: 32376621
[TBL] [Abstract][Full Text] [Related]
36. Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen inhibits lytic replication by targeting Rta: a potential mechanism for virus-mediated control of latency.
Lan K; Kuppers DA; Verma SC; Robertson ES
J Virol; 2004 Jun; 78(12):6585-94. PubMed ID: 15163750
[TBL] [Abstract][Full Text] [Related]
37. ERK1/2 and MEK1/2 induced by Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) early during infection of target cells are essential for expression of viral genes and for establishment of infection.
Sharma-Walia N; Krishnan HH; Naranatt PP; Zeng L; Smith MS; Chandran B
J Virol; 2005 Aug; 79(16):10308-29. PubMed ID: 16051824
[TBL] [Abstract][Full Text] [Related]
38.
Kang SK; Kang YH; Yoo SM; Park C; Kim HS; Lee MS
J Virol; 2021 Jul; 95(16):e0079921. PubMed ID: 34105998
[TBL] [Abstract][Full Text] [Related]
39. RUNX3 inhibits KSHV lytic replication by binding to the viral genome and repressing transcription.
Ren P; Niu D; Chang S; Yu L; Ren J; Ma Y; Lan K
J Virol; 2024 Feb; 98(2):e0156723. PubMed ID: 38197631
[TBL] [Abstract][Full Text] [Related]
40. Virus-Like Vesicles of Kaposi's Sarcoma-Associated Herpesvirus Activate Lytic Replication by Triggering Differentiation Signaling.
Gong D; Dai X; Xiao Y; Du Y; Chapa TJ; Johnson JR; Li X; Krogan NJ; Deng H; Wu TT; Sun R
J Virol; 2017 Aug; 91(15):. PubMed ID: 28515293
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]